A controlled study of 2 doses of idebenone in the treatment of Alzheimer's disease.

Weyer, G; Babej-Dölle, R M; Hadler, D; Hofmann, S; Herrmann, W M

Weyer, G; Babej-Dölle, R M; Hadler, D; Hofmann, S; Herrmann, W M.

Affiliation

Weyer G; Institute of Psychology, Johann Wolfgang Goethe University, Frankfurt/Main, Germany.

Neuropsychobiology ; 36(2): 73-82, 1997.

Article in En | MEDLINE | ID: mdl-9267856

Subject(s)

Alzheimer Disease/drug therapy; Benzoquinones/therapeutic use; Aged; Aged, 80 and over; Alzheimer Disease/psychology; Benzoquinones/adverse effects; Cognition/drug effects; Double-Blind Method; Female; Humans; Male; Middle Aged; Treatment Outcome; Ubiquinone/analogs & derivatives

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Benzoquinones / Alzheimer Disease Type of study: Clinical_trials Limits: Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Neuropsychobiology Year: 1997 Document type: Article Affiliation country: Germany Country of publication: Switzerland

Search on Google

Add to My VHL

XML

PubMed Links